Literature DB >> 28691476

Genetic effects of Vicryl® on fibroblast primary culture.

A Baj1,2, G A Beltramini1,2, M Romano1,2, D Lauritano3, R M Gaudio4, A Palmieri5, F Cura5, A B Giannì1,2.   

Abstract

Vicryl® (polyglactin 910) is an absorbable, synthetic, usually braided suture, indicated for soft tissue approximation and ligation. Vicryl® has a special coating for minimizing friction, easing passage through tissue and easy knot tie down. It is synthetic for minimal tissue reaction. Fibroblasts are the main cells of connective tissue that synthesize extracellular matrix. In this work, we tried to judge the action of Vicryl® on fibroblasts behaviour. We evaluated the expression levels of some adhesion and traction-resistance related genes (ELN, DSP, FN1, FBN1, ITGB1, ITGA1, ITGA5, ITGA2, COL1A1, COL3A1) by using real time Reverse Transcription-Polymerase Chain Reaction (real time RT-PCR). All but 2 genes resulted up-regulated after 48 h of treatment. Our preliminary results point out the potential of Vicryl® as a biocompatible and regenerative tool in medicine.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28691476

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  1 in total

1.  Second Generation of Tissue-Engineered Ligament Substitutes for Torn ACL Replacement: Adaptations for Clinical Applications.

Authors:  Franck Simon; Jadson Moreira-Pereira; Jean Lamontagne; Rejean Cloutier; Francine Goulet; Stéphane Chabaud
Journal:  Bioengineering (Basel)       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.